Human granulocytic ehrlichiosis in the United States

Infections in Medicine

Volumn 13, Issue 10, 1996, Pages 877-889

  Bakken, Johan S ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Duluth Clinic   (United States)

Author keywords

Doxycycline; Ehrlichia equi; Human granulocytic ehrlichiosis (HGE); Ixodes scapularis; Tick borne infections

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; DIETHYLTOLUAMIDE; DOXYCYCLINE; INSECT REPELLENT; MACROLIDE; RIFAMPICIN; TETRACYCLINE;

ACUTE PHASE RESPONSE; ARTICLE; BORRELIA BURGDORFERI; CELL INCLUSION; CONVALESCENCE; DRUG EFFICACY; EHRLICHIA; EHRLICHIOSIS; FEVER; GRANULOCYTE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IXODES; LYME DISEASE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; SEROCONVERSION; TICK BORNE DISEASE;

EID: 0030410843     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Donatien A, Lestoquard F: Existence en Algerie d'une rickettsia du chien. Bull Soc Pathol Exot 28:418-419, 1935.
2. Wen B, Rikihisa Y, Mott J, et al: Ehrlichia muris sp. nov., identified on the basis of 16S rRNA base sequences and serological, morphological, and biological characteristics. Int J System Bacteriol 45:250-254,1995.
3. Walker D, Dumler SJ: Emergence of ehrlichioses as a human problem. Emerg Infect Dis 2:18-29, 1996.
4. FukudaT, Keida Y, Kitao T: Studies on causative agent of "Hyuga netsu" disease. Med Biol 23:200-205,1954.
5. Maeda KE, Markowitz N, Hawley RC, et al: Human infection with Ehrlichia canis, a leukocytic rickettsia. N Engl J Med 316:853-856,1987.
6. Morais JD, Dawson JE, Green C, et al: First European case of Ehrlichiosis. Lancet 338:633-634, 1991.
7. Guerrero A, Fishbein DB, Mesa E, et al: Infeccion humana por Ehrlichia canis en Espana? Medicina Clinica (Barcelona) 96:56-57, 1991.
8. Pierard D, Levtchenko E, Dawson JE, et al: Ehrlichiosis in Belgium. Lancet 346:1233-1234, 1995.
9. Uhaa IJ, Maclean JD, Greene C, et al: A case of human ehrlichiosis acquired in Mali: Clinical and laboratory findings. Am J Trop Med Hyg 46:161-164, 1992.
10. Bakken JS, Dumler JS, Chen S-M, et al: Human granulocytic ehrlichiosis in the United States: Anew species emerging? JAMA 272:212-218, 1994.
11. Dumler JS, Bakken JS: Ehrlichial diseases of humans: Emerging tick-borne infections. Clin Infect Dis 20:1102-1110, 1995.
12. Brouqui P, Dumler JS, Lienhard R, et al: Human granulocytic ehrlichiosis in Europe. Lancet 346:782-783, 1995.
13. Sumption KJ, Wright DJM, Cutler SJ, et al: Human ehrlichiosis in the UK. Lancet 346:1487-1488, 1995.
14. Bakken JS, Krueth J, Tilden RL, et al: Serological evidence of human granulocytic ehrlichiosis in Norway. Europ J Clin Microbiol 1996, In press.
15. Bakken JS, Krueth J, Wilson-Nordskog C, et al: Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275:199-205, 1996.
16. Bakken JS, Krueth J, Lund T, et al: Human granulocytic ehrlichiosis possibly contracted through exposure to blood from deer. Clin Infect Dis 23:198, 1996.
17. Fish D: Environmental risk and prevention of Lyme disease. Am J Med 98 (suppl 4A):2S-10S, 1995.
18. Wormser G, McKenna D, Aguera-Rosenfeld M, et al: Human granulocytic ehrlichiosis in New York 1995. MMWR 44:593-595, 1995.
19. Goodman JL, Nelson C, Vitale B, et al: Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 334:209-215, 1996.
20. Chen S-M, Dumler JS, Bakken JS, et al: Identification of a granulocytic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 32:589-595, 1994.
21. Pancholi P, Kolbert CP, Mitchell P, et al: Ixodes dammini (scapularis) as a potential vector of human granulocytic ehrlichiosis. J Infect Dis 172:1007-1012, 1995.
22. Dumler JS, Bakken JS, Mitchell PD, et al: Human granulocytic ehrlichiosis (HGE), Lyme Disease, and babesiosis in the upper Midwest: Evidence for concurrent infections. Program and Abstracts of the 35th International Congress of Antibiotics and Chemotherapy, San Francisco, 1995. Abstract K29.
23. Mitchell PD, Reed KD, Hofkes JM, et al: Immunoserologic evidence of co-infection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents in Wisconsin and Minnesota. J Clin Microbiol 34:724-727, 1996.
24. Magnarelli LA, Dumler JS, Anderson JF, et al: Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrtichiosis, and Lyme borreliosis in human sera. J Clin Microbiol 33:3054-3057, 1995.
25. Wormser GP, Horowitz HW, Dumler JS, et al: False-positive Lyme disease serology in human granulocytic ehrlichiosis. Lancet 347:981-982, 1996.
26. Brouqui P, Raoult D: In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob Agents Chemother 36:2799-2803, 1992.
27. Spach DH, Liles WC, Campbell GL, et al: Tick-borne diseases in the United States. N Engl J Med 329:936-947, 1993.